Market Tracker

12/11 12:09pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

0.8873
BATS BZX Real-Time Price
As of 12:07pm ET
 -0.0184 / -2.03%
Today’s Change
0.79
Today|||52-Week Range
2.75
-60.56%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close0.91
Today’s open0.94
Day’s range0.88 - 0.94
Volume7,018
Average volume (3 months)694,133
Market cap$94.2M
Dividend yield--
Data as of 12:07pm ET, 12/11/2017

Growth & Valuation

Earnings growth (last year)-43.52%
Earnings growth (this year)+35.48%
Earnings growth (next 5 years)--
Revenue growth (last year)-94.25%
P/E ratioNM
Price/Sales99.52
Price/Book0.85

Competitors

 Today’s
change
Today’s
% change
STDYSteadymed Ltd-0.23-6.70%
GEMPGemphire Therapeutic...+0.20+2.49%
GLMDGalmed Pharmaceutica...+0.02+0.25%
GTXIGTX Inc+0.10+0.80%
Data as of 12:08pm ET, 12/11/2017

Financials

Next reporting dateFebruary 21, 2018
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$1.2M
Annual profit (last year)-$81.8M
Net profit margin-6,853.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, COO &
Director
Joseph P. Hagan
Chief Financial &
Accounting Officer
Daniel R. Chevallard
Corporate headquarters
San Diego, California

Forecasts